Back

Does previous use of acetilsalicilic acid for primary prevention of cardiovascular disease have a prognostic impact in patients with acute coronary syndrome?

3 March 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - ST Elevation Acute Coronary Sydrome - General Acute Coronary Sydrome Acute Coronary Syndromes: Drug Treatment, Other ACVC Premium Access Acute Cardiovascular Care 2018

About the speaker

Photo
Doctor Joao Pedro De Sousa Bispo

Faro Hospital, Faro (Portugal)

40 More presentations in this session

Presentation thumbnail
Association between central venous pressure, left ventricular function and acute cardiorenal syndrome in ST segment elevation myocardial infarction patients
Professor Y. Shacham (Tel Aviv, IL)
Abstract
Presentation thumbnail
Right atrial pressure predicts worsening renal function in patients with acute right ventricular myocardial infarction
Doctor E. Flores Umanzor (Barcelona, ES)
Presentation thumbnail
Causes, outcomes and factors predicting mortality in non-reperfused STEMI patients in the contemporary era
Doctor D. Araiza Garaygordobil (Ciudad de Mexico, MX)
Abstract
Presentation thumbnail
Vasoprotective effect of high doses of atorvastatin in patients with STEMI
Professor V. Oleinikov (Penza, RU)
Abstract
Presentation thumbnail
Comparative characteristic of deformation parameters in patients with anterior and posterior myocardial infarction
Professor V. Oleinikov (Penza, RU)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - ST Elevation Acute Coronary Sydrome - General Acute Coronary Sydrome

The Event

Event poster

Acute Cardiovascular Care 2018

3 March - 5 March 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources